Videregen

Business Services · United Kingdom · 11-50 Employees

View Company Info for Free

Overview

Headquarters

22 Victoria Ave, Harrogate, North Yorksh...

Phone Number

+44 1514829350

Revenue

$6.2 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Videregen

Videregen specializes in tissue repair by leveraging advances in thymus stem cell science to address diseases related to thymus dysfunction, aging, and autoimmunity. Their proprietary BioThymus technology platform aims to rejuvenate thymus function, enhancing T cell development and potentially treating conditions like athymia and transplant tolerance. The company targets clients in the medical and healthcare sectors, particularly those focused on immunology and regenerative medicine. By addressing age-related immune deterioration, Videregen's innovations may offer solutions for halting or reversing age-related pathologies.Explore more
Videregen's Social MediaPopular Searchesvideregen LtdVideregenA Regenerative Medicine CoSIC Code 87,873NAICS Code 54,541Show more

Is Videregen your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Videregen

Compare insights from companies similar to Videregen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Videregen

$6.2M
11-50
Private
$6.4M
2011
N/A
$6.2M
11-50
Private
$71.9M
2007
Flagg Flanagan, Chief Executive Officer & Chairman at DiscGenics
Flagg FlanaganCEO & Chairman
<$5M
11-50
Private
$5.3M
2013
SB
Sarindr BhumiratanaChief Scientific Officer
<$5M
11-50
Private
$33.4M
2006
MJ
Mia JansenGlobal Vice President, Supply Chain
<$5M
11-50
Public
$8.4M
2004
<$5M
1-10
Private
-
2007
LM
Lisa Martinez-SomersBusiness Development Manager
<$5M
1-10
Private
-
2010
Benjamin Austring, Chief Operating Officer at RepliCel Life Sciences
Benjamin AustringChief Operating Officer
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Videregen is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Videregen is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Videregen.

Videregen financials insights

Gather financial insights about Videregen, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2014

Multiple Rounds

$6.4M

See All Videregen's Financials Insights

Videregen Tech Stack

A closer look at the technologies used by Videregen

Top Business Services Companies

Frequently Asked Questions Regarding Videregen

What is Videregen's official website?
Videregen's official website is www.videregen.com
What is Videregen's Revenue?
Videregen's revenue is $6.2 Million
What is Videregen's SIC code?
Videregen's SIC: 87,873
What is Videregen's NAICS code?
Videregen's NAICS: 54,541
How many employees does Videregen have?
Videregen has 11-50 employees
What industry does Videregen belong to?
Videregen is in the industry of: Business Services, Research & Development
What is Videregen competition?
Videregen top competitors include: CollPlant Biotechnologies, DiscGenics, SpinalCyte, InGeneron
What technology does Videregen use?
Some of the popular technologies that Videregen uses are: WordPress.org, PHP, Unix, Google Font API
How do I contact Videregen?
Videregen contact info: Phone number: +44 1514829350 Website: www.videregen.com
What does Videregen do?

Videregen specializes in tissue repair by leveraging advances in thymus stem cell science to address diseases related to thymus dysfunction, aging, and autoimmunity. Their proprietary BioThymus technology platform aims to rejuvenate thymus function, enhancing T cell development and potentially treating conditions like athymia and transplant toleran... ce. The company targets clients in the medical and healthcare sectors, particularly those focused on immunology and regenerative medicine. By addressing age-related immune deterioration, Videregen's innovations may offer solutions for halting or reversing age-related pathologies.Read More

What are Videregen social media links?
Videregen Linkedin page Videregen Twitter page
Who invested in Videregen?
Videregen has 3 investors including London Business Angel, North West Fund for Biomedical and North West Fund.
Is Videregen a public company?
Videregen is private company therefore does not currently have an official ticker symbol
See more information about Videregen

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.